Universe Pharmaceuticals Inc (UPC)

Mar 21, 2025

Universe Pharmaceuticals stock plunges to 52-week low of $0.08 By Investing.com - Investing.com Australia

Mar 21, 2025

Mar 21, 2025

Universe Pharmaceuticals stock plunges to 52-week low of $0.08 - Investing.com

Mar 21, 2025

Mar 20, 2025

Universe Pharmaceuticals Announces Share Consolidation - TipRanks

Mar 20, 2025

Mar 20, 2025

Universe Pharmaceuticals Plans To Effect Share ConsolidationQuick Facts - Nasdaq

Mar 20, 2025

Mar 20, 2025

Universe Pharmaceuticals INC Announces Share Consolidation Effective March 24, 2025 - Nasdaq

Mar 20, 2025

Mar 20, 2025

Universe Pharmaceuticals INC Announces Share Consolidation - GlobeNewswire

Mar 20, 2025

Mar 20, 2025

Major Shake-up: Universe Pharmaceuticals Announces 40:1 Share ConsolidationWhat It Means For Investors - StockTitan

Mar 20, 2025

Mar 14, 2025

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Mar 14, 2025

Mar 14, 2025

Universe Pharmaceuticals stock plunges to 52-week low of $0.1 By Investing.com - Investing.com South Africa

Mar 14, 2025

Mar 14, 2025

Universe Pharmaceuticals stock plunges to 52-week low of $0.1 - Investing.com India

Mar 14, 2025

Mar 13, 2025

Universe Pharmaceuticals (NYSE:UPC) Trading Down 4.3% – What’s Next? - Defense World

Mar 13, 2025

Mar 12, 2025

Pre-market Movers: HCTI, HEPA, ZYXI, SYRS ... - RTTNews

Mar 12, 2025

Mar 11, 2025

Universe Pharmaceuticals Approves Share Consolidation at Extraordinary Meeting - TipRanks

Mar 11, 2025

Mar 10, 2025

UPC’s price-to-book ratio: An indicator of the company’s performance - US Post News

Mar 10, 2025

Mar 03, 2025

Universe Pharmaceuticals Adjourns Shareholder Meeting Due to Lack of Quorum - TipRanks

Mar 03, 2025

Feb 27, 2025

Universe Pharmaceuticals stock plunges to 52-week low of $0.14 - Investing.com India

Feb 27, 2025

Feb 27, 2025

Universe Pharmaceuticals stock plunges to 52-week low of $0.14 By Investing.com - Investing.com South Africa

Feb 27, 2025

Feb 26, 2025

Universe Pharmaceuticals receives notice from Nasdaq related to delayed annual report - MSN

Feb 26, 2025

Feb 26, 2025

Universe Pharmaceuticals faces potential Nasdaq delisting By Investing.com - Investing.com Australia

Feb 26, 2025

Feb 25, 2025

Universe Pharmaceuticals faces potential Nasdaq delisting - Investing.com India

Feb 25, 2025

Feb 25, 2025

Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report - The Manila Times

Feb 25, 2025

Feb 25, 2025

Universe Pharmaceuticals Faces Nasdaq Delisting Risk Due to Delayed Annual Report - TipRanks

Feb 25, 2025

Feb 25, 2025

Universe Pharmaceuticals INC Faces Potential Delisting from Nasdaq Due to Delinquent Annual Report Filing - Nasdaq

Feb 25, 2025

Feb 25, 2025

Will Universe Pharmaceuticals Survive Nasdaq's Latest Delisting Threat? - StockTitan

Feb 25, 2025

Feb 24, 2025

Looking Into Universe Pharmaceuticals's Recent Short Interest - Benzinga

Feb 24, 2025

Feb 23, 2025

Promising Chinese Stocks Worth Watching – February 21st - Defense World

Feb 23, 2025

Feb 21, 2025

Dow Tumbles Over 700 Points; US Services PMI Falls In February - Benzinga

Feb 21, 2025

Feb 21, 2025

Stock market today: Nuburu surged by 81.61% while Aspire Biopharma Holdings plummented by 44.32% in early trading - Business Upturn

Feb 21, 2025

Feb 21, 2025

Why Five9 Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga

Feb 21, 2025

Feb 20, 2025

Universe Pharmaceuticals Adjourns Shareholder Meeting Indefinitely - TipRanks

Feb 20, 2025

Feb 18, 2025

Universe Pharmaceuticals Adjourns Extraordinary General Meeting Due to Lack of Quorum - TipRanks

Feb 18, 2025

Feb 18, 2025

Volcon, Inc. and GlucoTrack, Inc. See Massive Gains, While Omega Therapeutics and Universe Pharmaceuticals Struggle - HPBL

Feb 18, 2025